Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Silo Pharma (SILO) Non Operating Income (2019 - 2025)

Historic Non Operating Income for Silo Pharma (SILO) over the last 7 years, with Q3 2025 value amounting to $41028.0.

  • Silo Pharma's Non Operating Income fell 4949.84% to $41028.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $230702.0, marking a year-over-year decrease of 3258.86%. This contributed to the annual value of $312814.0 for FY2024, which is 3933.25% up from last year.
  • Per Silo Pharma's latest filing, its Non Operating Income stood at $41028.0 for Q3 2025, which was down 4949.84% from $44258.0 recorded in Q2 2025.
  • In the past 5 years, Silo Pharma's Non Operating Income registered a high of $7.0 million during Q3 2021, and its lowest value of -$164117.0 during Q2 2022.
  • Moreover, its 5-year median value for Non Operating Income was $62684.0 (2025), whereas its average is $387388.2.
  • Over the last 5 years, Silo Pharma's Non Operating Income had its largest YoY gain of 1074054.89% in 2021, and its largest YoY loss of 115717.26% in 2021.
  • Silo Pharma's Non Operating Income (Quarter) stood at -$114629.0 in 2021, then soared by 94.88% to -$5873.0 in 2022, then soared by 2009.55% to $112148.0 in 2023, then dropped by 26.23% to $82732.0 in 2024, then crashed by 50.41% to $41028.0 in 2025.
  • Its last three reported values are $41028.0 in Q3 2025, $44258.0 for Q2 2025, and $62684.0 during Q1 2025.